Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months.

Autor: Karkanitsa M; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Li Y; Joint Program in Survey Methodology, Department of Epidemiology and Biostatistics, University of Maryland College Park, College Park, MD 20742., Valenti S; Clinical and Translational Science Institute (CTSI), University of Pittsburgh, Pittsburgh, PA 15213., Spathies J; Trans-NIH Shared Resource on Biomedical Engineering and Physical Science (BEPS), NIBIB, NIH, Bethesda MD 20894., Kelly S; Trans-NIH Shared Resource on Biomedical Engineering and Physical Science (BEPS), NIBIB, NIH, Bethesda MD 20894., Hunsberger S; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20894., Yee L; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH, MD 20894., Croker JA; Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA., Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Alfonso AL; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Faust M; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Mehalko J; Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702., Drew M; Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702., Denson JP; Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702., Putman Z; Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702., Fathi P; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Ngo TB; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Siripong N; Clinical and Translational Science Institute (CTSI), University of Pittsburgh, Pittsburgh, PA 15213., Baus HA; Laboratory of Immunoregulation, NIAID, NIH, Bethesda MD 20894., Petersen B; Clinical and Translational Science Institute (CTSI), University of Pittsburgh, Pittsburgh, PA 15213., Ford EW; Department of Health Care Organization, and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA., Sundaresan V; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Josyula A; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Han A; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Giurgea LT; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Rosas LA; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Bean R; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Athota R; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Czajkowski L; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Klumpp-Thomas C; National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, MD 20850., Cervantes-Medina A; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Gouzoulis M; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Reed S; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894., Graubard B; Division of Cancer Epidemiology & Genetics, Biostatistics Branch, NCI, NIH, Bethesda, MD 20894., Hall MD; National Center for Advancing Translational Sciences (NCATS), NIH, Rockville, MD 20850., Kalish H; Trans-NIH Shared Resource on Biomedical Engineering and Physical Science (BEPS), NIBIB, NIH, Bethesda MD 20894., Esposito D; Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702., Kimberly RP; Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA., Reis S; Clinical and Translational Science Institute (CTSI), University of Pittsburgh, Pittsburgh, PA 15213., Sadtler K; Section on Immunoengineering, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda MD 20894., Memoli MJ; LID Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20894.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Oct 21. Date of Electronic Publication: 2023 Oct 21.